TruAlt Bioenergy IPO: A Comprehensive Guide for Indian Investors
TruAlt Bioenergy Ltd.’s initial public offering (IPO) has been subscribed 0.81 times on its second day of bidding on Friday, with the company aiming to raise nearly Rs 839.28 crore from the primary market. In this article, we will delve into the details of the TruAlt Bioenergy IPO, including its subscription status, grey market premium, and key information for Indian investors.
TruAlt Bioenergy IPO: Subscription Status
The TruAlt Bioenergy IPO is a book-built issue that comprises a fresh issue of 1.51 crore shares aggregating Rs 750 crore and an offer-for-sale of 0.18 crore shares totalling Rs 89.28 crore. The IPO has a price band set between Rs 472 and Rs 496 per share, with each lot size consisting of 30 shares.
As of 5:00 p.m. on Friday, the subscription status of the TruAlt Bioenergy IPO was as follows:
- Institutional investors (QIB): 0.87 times or 87%.
- Non-Institutional investors (NII): 0.80 times or 80%.
- Retail investors: 0.79 times or 79%.
TruAlt Bioenergy IPO: Grey Market Premium (GMP)
The latest grey market premium of TruAlt Bioenergy is Rs 92 as of 8:00 p.m. according to Investorgain.com. The stock’s estimated listing price is Rs 588, implying a gain of 18.55% over the IPO price of Rs 496.
Note: GMP does not represent official data and is based on speculation. GMP data sourced from InvestorGain.
TruAlt Bioenergy IPO: Key Details for Indian Investors
Here are some key details that Indian investors should know about the TruAlt Bioenergy IPO:
- IPO Schedule: The TruAlt Bioenergy IPO is scheduled to open on September 25 and will close on September 29.
- Minimum Investment: The retail investors require a minimum investment of Rs 14,880 at the upper price band. For Small Non-Institutional Investors (sNII), the minimum investment is 14 lots or 420 shares, totalling Rs 2,08,320. For Big Non-Institutional Investors (bNII), it is 68 lots or 2,040 shares, amounting to Rs 10,11,840.
- Basis of Allotment: The basis of allotment is expected to be finalised on September 30.
- Listing Date: The tentative listing date for TruAlt Bioenergy on the BSE and NSE is October 3.
TruAlt Bioenergy: Company Overview
Founded in 2021, TruAlt Bioenergy is primarily engaged in the production of biofuels, with a strong focus on the ethanol segment. The company has reported a significant jump in total income and profit after tax in the financial year ended March 31.
For the financial year ended March 31, TruAlt Bioenergy reported a total income of Rs 1,968.53 crore, up from Rs 1,280.19 crore the previous year. Profit after tax also saw strong growth, increasing to Rs 146.64 crore from Rs 31.81 crore. Ebitda for the same period stood at Rs 309.14 crore, compared to Rs 188.09 crore in FY24.
Conclusion
The TruAlt Bioenergy IPO is an opportunity for Indian investors to participate in the growth story of a company that is focused on the production of biofuels. With a strong financial performance and a growing demand for biofuels, TruAlt Bioenergy is well-positioned to capitalize on the emerging trends in the energy sector.
However, as with any investment, it is essential to do your own research and consider your own risk tolerance before investing in the TruAlt Bioenergy IPO. We recommend that you consult with a financial advisor or a broker to get a better understanding of the IPO and its potential risks and rewards.
For more information on the TruAlt Bioenergy IPO, including its subscription status, grey market premium, and key details, please visit our website or follow us on social media.
Visit our IPO news section for the latest updates on upcoming IPOs and listings.
Visit our stock market news section for the latest updates on the Indian stock market and economy.